A Randomized, Double-Blind, Parallel-Group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension

This study has been completed.

Study NCT00133185 Information provided by Boehringer Ingelheim Pharmaceuticals

First Received: August 22, 2005 Last Updated: March 2, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	January 2005
Estimated Primary Completion Date:	No date given